Research & Development



  長平自然是堅強的,甚至是強悍的,從頭到尾沒有流一滴眼淚,然而,她的悲傷卻長久的彌漫在這座豪奢的長公主府邸盤旋不去。   曹襄則對雲瑯怒目而視,大聲道︰“環佩玎不好麼?為什麼一定是鈴鐺?”色一把-色一把伦理   霍光笑道︰“可是要運去蜀中?”色一把看片网站   隋越等李姬完全消失了,才拱手道︰“從雲氏傳來的消息看,阿嬌如今正在與長公主對飲。”   公孫弘連忙笑道︰“陛下那里的話,臣等不過是在閑聊,說一些趣話,陛下如果想听,臣等自然求之不得。”色一下   自從雲瑯來到大漢,听說過可以對前朝余孽施行仁政的說法,對皇帝時不時地大赦天下的行為保留贊許態度。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo